Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study

Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (MetS). Levels of plasminogen activator inhibitor-1 (PAI-1), an inhibitor of tissue-type and urokinase-type plasminogen activators, are associated with MetS. To clarify the role of PAI-1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Huotari, Anne, Lehto, Soili M., Niskanen, Leo, Herzig, Karl-Heinz, Hintikka, Jukka, Koivumaa-Honkanen, Heli, Tolmunen, Tommi, Honkalampi, Kirsi, Kaikkonen, Noora, Viinamäki, Heimo
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838223/
https://www.ncbi.nlm.nih.gov/pubmed/20300596
http://dx.doi.org/10.1155/2010/501349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838223/
https://www.ncbi.nlm.nih.gov/pubmed/20300596
http://dx.doi.org/10.1155/2010/501349

Ejemplares similares